Effects of Chewing Gum Against Postoperative Ileus

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04768660
Collaborator
(none)
10
1
26.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether the use of chewing gum effects postoperative ileus after pancreaticoduodenectomy

Condition or Disease Intervention/Treatment Phase
  • Other: gum
N/A

Detailed Description

Postoperative ileus is common after surgery. One non-pharmacological intervention that has shown promising results in reducing the duration of postoperative ileus is chewing gum after surgery. However, this has not been investigated in upper gastrointestinal surgery such as pancreatic surgery. Hence the aim of this study was to investigate the effects of chewing gum treatment on patients undergoing pancreaticoduodenectomy due to pancreatic or periampullary cancer.

This study was conducted as a phase-III trial. Patients diagnosed with pancreatic tumours scheduled for pancreaticoduodenectomy were included. The treatment group received chewing gum postoperatively and standard care. Controls received glucose solution and standard care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Use of Non-pharmacological Agent to Accelerate Gastrointestinal Recovery in Patients Undergoing Pancreatic Head Resection
Anticipated Study Start Date :
Feb 14, 2021
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: normal

people will not use chewing gums after whipple operation

Other: gum
Other: Chewing gum ChiczaTM organic chewing gum 6 pieces a day Other: Glucose 12ml glucose solution (13,6g) per day

Outcome Measures

Primary Outcome Measures

  1. First flatus after surgery [(with in the first 21 days)]

    From day of surgery until first postoperative flatus

  2. Length of hospital stay [(with in the first 21 days) ]]

    Time Frame: From day of surgery until discharge from surgical ward

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Pancreatic or periampullary cancer and scheduled to undergo pancreaticoduodenectomy.
Exclusion Criteria:
    1. Ongoing treatment for mental disease 3. Diagnosed neurological injuries or diseases affecting the ability to swallow or gastric function 4. Ongoing abuse of alcohol or other drugs 5. Previously known allergies to the content of chewing gum 6. Additional surgery after primary surgery.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrew Mokbel, andrew mokbel mahani sawers, Assiut University
ClinicalTrials.gov Identifier:
NCT04768660
Other Study ID Numbers:
  • chewing gum postoperative
First Posted:
Feb 24, 2021
Last Update Posted:
Feb 24, 2021
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2021